3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Sarcoma
26
Gliosarcoma
22
Glioblastoma
21
Glioma
16
Ependymoma
15
Astrocytoma
12
Osteosarcoma
11
Oligodendroglioma
11
Central Nervous System Neoplasms
10
Rhabdomyosarcoma
9
Medulloblastoma
9
Sarcoma, Ewing
7
Neuroblastoma
7
Glioma, Subependymal
7
Brain Neoplasms
7
Rhabdoid Tumor
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Neuroectodermal Tumors, Primitive
6
Neoplasm Metastasis
6
Lymphoma, Non-Hodgkin
6
Lung Neoplasms
6
Histiocytosis, Langerhans-Cell
6
Carcinosarcoma
6
Wilms Tumor
5
Liposarcoma
5
Hepatoblastoma
5
Carcinoma, Transitional Cell
5
Sarcoma, Kaposi
4
Ovarian Neoplasms
4
Meningioma
4
Interventions
regorafenib
2
Doxorubicin
2
Cyclophosphamide
2
Cisplatin
2
tislelizumab
1
tazemetostat
1
sodium thiosulfate
1
entinostat
1
alanosine
1
X-Rays
1
Tamoxifen
1
Specimen Handling
1
Radiotherapy
1
Platinum
1
Magnetic Resonance Spectroscopy
1
Hyperthermic Intraperitoneal Chemotherapy
1
Fentanyl
1
Etoposide
1
Erlotinib Hydrochloride
1
Cytoreduction Surgical Procedures
1
Clinical Trials, Phase II as Topic
1
Celecoxib
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Magnetic Resonance Spectroscopy
×
Sarcoma
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled